Global Digital Behavioural Health Services Market, By Technology (Telecare, Telehealth), mHealth (Wearables, Apps, Digital Health System), End Use (Providers, Community Clinics, Hospitals, Private Practices, Payers, Patients) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Behavioural health issues are caused by a lack of positive emotions, as well as a variety of physical, emotional, and behavioural symptoms. It is a very common symptom that affects 1 in every 5 people. A person may require various types of behavioural health services. Behavioural health problems affect 7.4 percent of children aged 3 to 18 years, and it is the second-leading cause of global disability. There are numerous factors that contribute to behavioural health issues.
- Data Bridge Market Research analyses that the Digital Behavioural Health Services market is expected to reach the value of USD 139.93 million by the year 2029, at a CAGR of 8.40% during the forecast period. “Healthcare providers” accounts for the largest end user segment in the Digital Behavioural Health Services market owning to the presence of government mandates and rise in healthcare costs.
Market Definition
Behavioural health is the biology of a person's well-being, ability to function in daily life, and behaviours. People with behavioural health issues may experience depression, anxiety, stress, addiction, learning disability, and mood disorder. In this case, behavioural health services can help with treatment. The conditions can be caused by biological factors such as genetics, anatomical structures, and chemicals, or by psychological factors such as trauma. Understanding the root cause of behavioural health issues can aid in determining the best treatment strategy.
Digital Behavioural Health Services Market Dynamics
Drivers
-
The rise in the adoption of digital health monitoring
Due to the general rise in the prevalence of round-the-clock inspection of patients and health monitoring of patients, the digital health monitoring devices market is expected to expand, driving the digital behavioural health services market. The familiarity of being healthy and fit and keeping track of it through the use of digital health gears is also expected to induce mammoth scale growth in the favour of digital behavioural health services market.
-
The increase in the cases of sleep disorders as well as apnea
This market's growth is being attributed to a variety of factors, including rising IT technologies, the digital revolution, user-friendly graphical interfaces, mobile devices for cardiac patients, advancing wireless monitoring devices, increased care prevalence, and a greater emphasis on quality-based treatment regimens, all of which are playing a significant role in market growth and business expansion globally for digital behavioural health services. The growing number of people battling sleep disorders and the population affected by sleep apnea has contributed to the potential growth of the digital behavioural health services market. This surge in business will continue in a fruitful cycle of maximum yield for the next seven years.
Opportunities
The budget for mental health services is growing. The government is launching new initiatives to improve treatment for people with behavioural health disorders. People are not using digital methods, such as software programmes, to deal with mental health issues. All of these factors will create opportunities in the market for behavioural health services.
Restraints/Challenges
During the forecasted period of 2022 to 2029, the digital behavioural health services market is expected to face some challenges, such as high costs required to maintain service compliance, and the restored data is vulnerable to damage or theft.
This Digital Behavioural Health Services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Digital Behavioural Health Services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Digital Behavioural Health Services Market
People with behavioural or mental health issues face numerous risks as a result of the covid-19. People with behavioural health problems are experiencing disruptions in treatment, lifeline support services, and medication as a result of the government's lockdown and social distancing guidelines, which is having a negative impact on the behavioural health services market. People are becoming more depressed as a result of the covid-19 pandemic, as they are confined to their homes all of the time. To prevent the spread of Coronavirus, people infected with Covid-19 must remain alone. As a result, it has an effect on their mental health. The growing prevalence of mental health issues is expected to propel the behavioural health services industry during the forecast period.
Recent Development
- Battery Ventures created a cloud-based software platform specifically designed for mental health centres to improve people's behavioural health in February 2021.
Global Digital Behavioural Health Services Market Scope
The digital behavioural health services market is segmented on the basis of technology, mhealth and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Telecare
- Telehealth
On the basis of technology, the digital behavioural health services market is segmented into telecare, telehealth. Telecare is further sub-segmented into activity monitoring, and remote medication management. Telehealth is further sub-segmented into LTC monitoring, and video consultation.
M Health
- Wearables
- Apps
- Digital health system
On the basis of mhealth, the digital behavioural health services market is segmented into wearables, apps, and digital health system. Wearables are further is sub-segmented into BP monitors, glucose meter, pulse oximeter, sleep apnea monitors, and neurological monitors. Apps are further bifurcated into medical, and fitness. Digital health system is further sub-segmented into EHR, and e-prescribing system.
End User
- providers
- community clinics
- hospitals
- private practices
- payers
- patients
On the basis of end use, the digital Behavioural health services market is sub-segmented into providers, community clinics, hospitals, private practices, payers, and patients.
Digital Behavioural Health Services Market Regional Analysis/Insights
The digital behavioural Health Services market is analysed and market size insights and trends are provided by country, technology, mhealth and end use.as referenced above.
The countries covered in the digital behavioural health services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the digital behavioural health services market due to a high prevalence of patients and thriving healthcare infrastructure, whereas Asia-Pacific is expected to grow at the fastest rate during the forecast period of 2022 to 2029 due to the focus of various established market players on expanding their presence in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The digital behavioural health services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital behavioural health services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital behavioural health services market. The data is available for historic period 2010-2020.
Competitive Landscape and Digital Behavioural Health Services Market Share Analysis
The digital behavioural health services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital behavioural health services market.
Some of the major players operating in the digital behavioural health services market are Allscripts Healthcare, LLC, BioTelemetry, Inc., eClinicalWorks, iHealth Labs Inc., McKesson Corporation, Koninklijke Philips N.V., AT&T Intellectual Property., Cerner Corporation, Cisco Systems, athenahealth, Inc., Qualcomm Technologies, Inc., NXGN Management, LLC, The Echo Group, Meditab among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE
5.2 PORTER
6 INDUSTRY INSIGHTS
6.1 PATENT ANALYSIS
6.2 DRUG TREATMENT RATE BY MATURED MARKETS
6.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
6.4 PATIENT FLOW DIAGRAM
6.5 KEY PRICING STRATEGIES
6.6 KEY PATIENT ENROLLMENT STRATEGIES
6.7 INTERVIEWS WITH NEUROLOGIST
6.8 INTERVIEWS WITH ONCOLOGISTS
6.9 OTHER KOL SNAPSHOTS
7 EPIDEMIOLOGY
7.1 INCIDENCE OF ALL BY GENDER
7.2 TREATMENT RATE
7.3 MORTALITY RATE
7.4 DRUG ADHERENCE AND THERAPY SWITCH MODEL
7.5 PATEINT TREATMENT SUCCESS RATES
8 REGULATORY & REIMBURSEMENT FRAMEWORK
9 PIPELINE ANALYSIS
9.1 CLINICAL TRIALS AND PHASE ANALYSIS
9.2 DIGITAL THERPEUTICS PIPELINE
9.3 OTHERS (PRE-CLINICAL AND RESEARCH)
10 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY TREATMENT
10.1 OVERVIEW
10.2 BY USAGE
10.2.1 MEDICATION AUGMENTATION
10.2.2 MEDICATION REPLACEMENT
10.3 BY TYPE
10.3.1 OUTPATIENT TREATMENT
10.3.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
10.3.1.2. FLUENCY TRAINING
10.3.1.3. CONTIGENCY MANAGEMENT
10.3.1.4. CRAVING AND TRIGGER ASSESSMENT
10.3.1.5. TRANSMUCOSAL BUPRENORPHINE
10.3.1.6. OTHERS
10.3.2 MONOTHERAPY
10.3.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
10.3.2.2. COGNITIVE RESTRUCTURING
10.3.2.3. OTHERS
10.3.3 COMBINATION THERAPY
10.3.3.1. SMART WATCH
10.3.3.2. WRISTWATCH/WRISTBAND
10.3.3.3. SMART CLOTHES
10.3.3.4. EAR BANDS
10.3.3.5. OTHERS
10.3.4 OTHERS
11 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY SERVICES
11.1 OVERVIEW
11.2 PHYSICAL ACITIVITY
11.3 RELAXATION TECHNIQUE
11.4 DIET OPTIMIZATION
11.5 CONTROLLED BREATHING
11.6 TELEMEDICINE
11.7 MINDFULNESS TRAINING
11.8 OTHERS
12 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY APP ACCESSIBILITY
12.1 OVERVIEW
12.2 ANDROID
12.2.1 SMARTPHONE
12.2.2 TABLET
12.3 IOS
12.3.1 SMARTPHONE
12.3.2 TABLET
12.4 WINDOWS
12.4.1 SMARTPHONE
12.4.2 TABLET
13 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY APP TYPE
13.1 OVERVIEW
13.2 NATIVE APPS
13.3 WEB APPS
13.4 HYBRID APPS
14 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
14.2.1 BY USAGE
14.2.1.1. MEDICATION AUGMENTATION
14.2.1.2. MEDICATION REPLACEMENT
14.2.2 BY TYPE
14.2.2.1. OUTPATIENT TREATMENT
14.2.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.2.2.1.2. FLUENCY TRAINING
14.2.2.1.3. CONTIGENCY MANAGEMENT
14.2.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.2.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.2.2.1.6. OTHERS
14.2.2.2. MONOTHERAPY
14.2.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.2.2.2.2. COGNITIVE RESTRUCTURING
14.2.2.2.3. OTHERS
14.2.2.3. COMBINATION THERAPY
14.2.2.3.1. SMART WATCH
14.2.2.3.2. WRISTWATCH/WRISTBAND
14.2.2.3.3. SMART CLOTHES
14.2.2.3.4. EAR BANDS
14.2.2.3.5. OTHERS
14.3 ALZHEIMER’S DISEASE
14.3.1 BY USAGE
14.3.1.1. MEDICATION AUGMENTATION
14.3.1.2. MEDICATION REPLACEMENT
14.3.2 BY TYPE
14.3.2.1. OUTPATIENT TREATMENT
14.3.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.3.2.1.2. FLUENCY TRAINING
14.3.2.1.3. CONTIGENCY MANAGEMENT
14.3.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.3.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.3.2.1.6. OTHERS
14.3.2.2. MONOTHERAPY
14.3.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.3.2.2.2. COGNITIVE RESTRUCTURING
14.3.2.2.3. OTHERS
14.3.2.3. COMBINATION THERAPY
14.3.2.3.1. SMART WATCH
14.3.2.3.2. WRISTWATCH/WRISTBAND
14.3.2.3.3. SMART CLOTHES
14.3.2.3.4. EAR BANDS
14.3.2.3.5. OTHERS
14.3.2.4. OTHERS
14.4 MAJOR DEPRESSIVE DISORDER (MDD)
14.4.1 BY USAGE
14.4.1.1. MEDICATION AUGMENTATION
14.4.1.2. MEDICATION REPLACEMENT
14.4.2 BY TYPE
14.4.2.1. OUTPATIENT TREATMENT
14.4.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.4.2.1.2. FLUENCY TRAINING
14.4.2.1.3. CONTIGENCY MANAGEMENT
14.4.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.4.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.4.2.1.6. OTHERS
14.4.2.2. MONOTHERAPY
14.4.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.4.2.2.2. COGNITIVE RESTRUCTURING
14.4.2.2.3. OTHERS
14.4.2.3. COMBINATION THERAPY
14.4.2.3.1. SMART WATCH
14.4.2.3.2. WRISTWATCH/WRISTBAND
14.4.2.3.3. SMART CLOTHES
14.4.2.3.4. EAR BANDS
14.4.2.3.5. OTHERS
14.4.2.4. OTHERS
14.5 INSOMNIA
14.5.1 BY USAGE
14.5.1.1. MEDICATION AUGMENTATION
14.5.1.2. MEDICATION REPLACEMENT
14.5.2 BY TYPE
14.5.2.1. OUTPATIENT TREATMENT
14.5.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.5.2.1.2. FLUENCY TRAINING
14.5.2.1.3. CONTIGENCY MANAGEMENT
14.5.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.5.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.5.2.1.6. OTHERS
14.5.2.2. MONOTHERAPY
14.5.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.5.2.2.2. COGNITIVE RESTRUCTURING
14.5.2.2.3. OTHERS
14.5.2.3. COMBINATION THERAPY
14.5.2.3.1. SMART WATCH
14.5.2.3.2. WRISTWATCH/WRISTBAND
14.5.2.3.3. SMART CLOTHES
14.5.2.3.4. EAR BANDS
14.5.2.3.5. OTHERS
14.5.2.4. OTHERS
14.6 COGNITION
14.6.1 BY USAGE
14.6.1.1. MEDICATION AUGMENTATION
14.6.1.2. MEDICATION REPLACEMENT
14.6.2 BY TYPE
14.6.2.1. OUTPATIENT TREATMENT
14.6.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.6.2.1.2. FLUENCY TRAINING
14.6.2.1.3. CONTIGENCY MANAGEMENT
14.6.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.6.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.6.2.1.6. OTHERS
14.6.2.2. MONOTHERAPY
14.6.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.6.2.2.2. COGNITIVE RESTRUCTURING
14.6.2.2.3. OTHERS
14.6.2.3. COMBINATION THERAPY
14.6.2.3.1. SMART WATCH
14.6.2.3.2. WRISTWATCH/WRISTBAND
14.6.2.3.3. SMART CLOTHES
14.6.2.3.4. EAR BANDS
14.6.2.3.5. OTHERS
14.6.2.4. OTHERS
14.7 EPILEPSY
14.7.1 BY USAGE
14.7.1.1. MEDICATION AUGMENTATION
14.7.1.2. MEDICATION REPLACEMENT
14.7.2 BY TYPE
14.7.2.1. OUTPATIENT TREATMENT
14.7.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.7.2.1.2. FLUENCY TRAINING
14.7.2.1.3. CONTIGENCY MANAGEMENT
14.7.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.7.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.7.2.1.6. OTHERS
14.7.2.2. MONOTHERAPY
14.7.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.7.2.2.2. COGNITIVE RESTRUCTURING
14.7.2.2.3. OTHERS
14.7.2.3. COMBINATION THERAPY
14.7.2.3.1. SMART WATCH
14.7.2.3.2. WRISTWATCH/WRISTBAND
14.7.2.3.3. SMART CLOTHES
14.7.2.3.4. EAR BANDS
14.7.2.3.5. OTHERS
14.7.2.4. OTHERS
14.8 MOVEMENT DISORDER
14.8.1 BY USAGE
14.8.1.1. MEDICATION AUGMENTATION
14.8.1.2. MEDICATION REPLACEMENT
14.8.2 BY TYPE
14.8.2.1. OUTPATIENT TREATMENT
14.8.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.8.2.1.2. FLUENCY TRAINING
14.8.2.1.3. CONTIGENCY MANAGEMENT
14.8.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.8.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.8.2.1.6. OTHERS
14.8.2.2. MONOTHERAPY
14.8.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.8.2.2.2. COGNITIVE RESTRUCTURING
14.8.2.2.3. OTHERS
14.8.2.3. COMBINATION THERAPY
14.8.2.3.1. SMART WATCH
14.8.2.3.2. WRISTWATCH/WRISTBAND
14.8.2.3.3. SMART CLOTHES
14.8.2.3.4. EAR BANDS
14.8.2.3.5. OTHERS
14.8.2.4. OTHERS
14.9 AUSTISM SPECTRUM DISORDER
14.9.1 BY USAGE
14.9.1.1. MEDICATION AUGMENTATION
14.9.1.2. MEDICATION REPLACEMENT
14.9.2 BY TYPE
14.9.2.1. OUTPATIENT TREATMENT
14.9.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.9.2.1.2. FLUENCY TRAINING
14.9.2.1.3. CONTIGENCY MANAGEMENT
14.9.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.9.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.9.2.1.6. OTHERS
14.9.2.2. MONOTHERAPY
14.9.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.9.2.2.2. COGNITIVE RESTRUCTURING
14.9.2.2.3. OTHERS
14.9.2.3. COMBINATION THERAPY
14.9.2.3.1. SMART WATCH
14.9.2.3.2. WRISTWATCH/WRISTBAND
14.9.2.3.3. SMART CLOTHES
14.9.2.3.4. EAR BANDS
14.9.2.3.5. OTHERS
14.9.2.4. OTHERS
14.1 ONCOLOGY
14.10.1 BY USAGE
14.10.1.1. MEDICATION AUGMENTATION
14.10.1.2. MEDICATION REPLACEMENT
14.10.2 BY TYPE
14.10.2.1. OUTPATIENT TREATMENT
14.10.2.1.1. COGNITIVE BEHAVIORAL THERAPY (CBT)
14.10.2.1.2. FLUENCY TRAINING
14.10.2.1.3. CONTIGENCY MANAGEMENT
14.10.2.1.4. CRAVING AND TRIGGER ASSESSMENT
14.10.2.1.5. TRANSMUCOSAL BUPRENORPHINE
14.10.2.1.6. OTHERS
14.10.2.2. MONOTHERAPY
14.10.2.2.1. INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBTI)
14.10.2.2.2. COGNITIVE RESTRUCTURING
14.10.2.2.3. OTHERS
14.10.2.3. COMBINATION THERAPY
14.10.2.3.1. SMART WATCH
14.10.2.3.2. WRISTWATCH/WRISTBAND
14.10.2.3.3. SMART CLOTHES
14.10.2.3.4. EAR BANDS
14.10.2.3.5. OTHERS
14.10.2.4. OTHERS
15 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY PATIENTS
15.1 OVERVIEW
15.2 CHILDREN
15.3 ADULTS
15.4 GERIATRICS
16 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.2 COMPANY SHARE ANALYSIS: EUROPE
16.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.4 MERGERS & ACQUISITIONS
16.5 NEW PRODUCT DEVELOPMENT & APPROVALS
16.6 EXPANSIONS
16.7 REGULATORY CHANGES
16.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, BY GEOGRAPHY
17.1 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.1.1 NORTH AMERICA
17.1.1.1. U.S.
17.1.1.2. CANADA
17.1.1.3. MEXICO
17.1.2 EUROPE
17.1.2.1. GERMANY
17.1.2.2. FRANCE
17.1.2.3. U.K.
17.1.2.4. HUNGARY
17.1.2.5. LITHUANIA
17.1.2.6. AUSTRIA
17.1.2.7. IRELAND
17.1.2.8. NORWAY
17.1.2.9. POLAND
17.1.2.10. ITALY
17.1.2.11. SPAIN
17.1.2.12. RUSSIA
17.1.2.13. TURKEY
17.1.2.14. NETHERLANDS
17.1.2.15. SWITZERLAND
17.1.2.16. REST OF EUROPE
17.1.3 ASIA-PACIFIC
17.1.3.1. JAPAN
17.1.3.2. CHINA
17.1.3.3. SOUTH KOREA
17.1.3.4. INDIA
17.1.3.5. AUSTRALIA
17.1.3.6. SINGAPORE
17.1.3.7. THAILAND
17.1.3.8. MALAYSIA
17.1.3.9. INDONESIA
17.1.3.10. PHILIPPINES
17.1.3.11. VIETNAM
17.1.3.12. REST OF ASIA-PACIFIC
17.1.4 SOUTH AMERICA
17.1.4.1. BRAZIL
17.1.4.2. ARGENTINA
17.1.4.3. PERU
17.1.4.4. REST OF SOUTH AMERICA
17.1.5 MIDDLE EAST AND AFRICA
17.1.5.1. SOUTH AFRICA
17.1.5.2. SAUDI ARABIA
17.1.5.3. UAE
17.1.5.4. EGYPT
17.1.5.5. KUWAIT
17.1.5.6. ISRAEL
17.1.5.7. REST OF MIDDLE EAST AND AFRICA
17.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
18 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, SWOT AND DBMR ANALYSIS
19 GLOBAL DIGITAL BEHAVIORAL HEALTH SERVICES MARKET, COMPANY PROFILE
19.1 PEAR THERAPEUTICS, INC.
19.1.1 COMPANY OVERVIEW
19.1.2 REVENUE ANALYSIS
19.1.3 GEOGRAPHIC PRESENCE
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPEMENTS
19.2 AKILI INTERACTIVE LABS, INC.
19.2.1 COMPANY OVERVIEW
19.2.2 REVENUE ANALYSIS
19.2.3 GEOGRAPHIC PRESENCE
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPEMENTS
19.3 CLICK THERAPEUTICS, INC.
19.3.1 COMPANY OVERVIEW
19.3.2 REVENUE ANALYSIS
19.3.3 GEOGRAPHIC PRESENCE
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPEMENTS
19.4 BETTER THERAPEUTICS, LLC
19.4.1 COMPANY OVERVIEW
19.4.2 REVENUE ANALYSIS
19.4.3 GEOGRAPHIC PRESENCE
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPEMENTS
19.5 XEALTH
19.5.1 COMPANY OVERVIEW
19.5.2 REVENUE ANALYSIS
19.5.3 GEOGRAPHIC PRESENCE
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPEMENTS
19.6 KAIA HEALTH
19.6.1 COMPANY OVERVIEW
19.6.2 REVENUE ANALYSIS
19.6.3 GEOGRAPHIC PRESENCE
19.6.4 PRODUCT PORTFOLIO
19.6.5 RECENT DEVELOPEMENTS
19.7 OMADA HEALTH, INC.
19.7.1 COMPANY OVERVIEW
19.7.2 REVENUE ANALYSIS
19.7.3 GEOGRAPHIC PRESENCE
19.7.4 PRODUCT PORTFOLIO
19.7.5 RECENT DEVELOPEMENTS
19.8 WELLDOC
19.8.1 COMPANY OVERVIEW
19.8.2 REVENUE ANALYSIS
19.8.3 GEOGRAPHIC PRESENCE
19.8.4 PRODUCT PORTFOLIO
19.8.5 RECENT DEVELOPEMENTS
19.9 VOLUNTIS
19.9.1 COMPANY OVERVIEW
19.9.2 REVENUE ANALYSIS
19.9.3 GEOGRAPHIC PRESENCE
19.9.4 PRODUCT PORTFOLIO
19.9.5 RECENT DEVELOPEMENTS
19.1 SOLERA NETWORK
19.10.1 COMPANY OVERVIEW
19.10.2 REVENUE ANALYSIS
19.10.3 GEOGRAPHIC PRESENCE
19.10.4 PRODUCT PORTFOLIO
19.10.5 RECENT DEVELOPEMENTS
19.11 2MORROW INC.
19.11.1 COMPANY OVERVIEW
19.11.2 REVENUE ANALYSIS
19.11.3 GEOGRAPHIC PRESENCE
19.11.4 PRODUCT PORTFOLIO
19.11.5 RECENT DEVELOPEMENTS
19.12 GAIA
19.12.1 COMPANY OVERVIEW
19.12.2 REVENUE ANALYSIS
19.12.3 GEOGRAPHIC PRESENCE
19.12.4 PRODUCT PORTFOLIO
19.12.5 RECENT DEVELOPEMENTS
19.13 RESMED
19.13.1 COMPANY OVERVIEW
19.13.2 REVENUE ANALYSIS
19.13.3 GEOGRAPHIC PRESENCE
19.13.4 PRODUCT PORTFOLIO
19.13.5 RECENT DEVELOPEMENTS
19.14 DTHERA SCIENCES
19.14.1 COMPANY OVERVIEW
19.14.2 REVENUE ANALYSIS
19.14.3 GEOGRAPHIC PRESENCE
19.14.4 PRODUCT PORTFOLIO
19.14.5 RECENT DEVELOPEMENTS
19.15 SAMSUNG
19.15.1 COMPANY OVERVIEW
19.15.2 REVENUE ANALYSIS
19.15.3 GEOGRAPHIC PRESENCE
19.15.4 PRODUCT PORTFOLIO
19.15.5 RECENT DEVELOPEMENTS
19.16 BIGHEALTH
19.16.1 COMPANY OVERVIEW
19.16.2 REVENUE ANALYSIS
19.16.3 GEOGRAPHIC PRESENCE
19.16.4 PRODUCT PORTFOLIO
19.16.5 RECENT DEVELOPEMENTS
19.17 PROPELLER HEALTH
19.17.1 COMPANY OVERVIEW
19.17.2 REVENUE ANALYSIS
19.17.3 GEOGRAPHIC PRESENCE
19.17.4 PRODUCT PORTFOLIO
19.17.5 RECENT DEVELOPEMENTS
19.18 F. HOFFMANN-LA ROCHE LTD
19.18.1 COMPANY OVERVIEW
19.18.2 REVENUE ANALYSIS
19.18.3 GEOGRAPHIC PRESENCE
19.18.4 PRODUCT PORTFOLIO
19.18.5 RECENT DEVELOPEMENTS
19.19 LIMBIX HEALTH, INC
19.19.1 COMPANY OVERVIEW
19.19.2 REVENUE ANALYSIS
19.19.3 GEOGRAPHIC PRESENCE
19.19.4 PRODUCT PORTFOLIO
19.19.5 RECENT DEVELOPEMENTS
19.2 NUVOAIR AB
19.20.1 COMPANY OVERVIEW
19.20.2 REVENUE ANALYSIS
19.20.3 GEOGRAPHIC PRESENCE
19.20.4 PRODUCT PORTFOLIO
19.20.5 RECENT DEVELOPEMENTS
19.21 ALTRAN
19.21.1 COMPANY OVERVIEW
19.21.2 REVENUE ANALYSIS
19.21.3 GEOGRAPHIC PRESENCE
19.21.4 PRODUCT PORTFOLIO
19.21.5 RECENT DEVELOPEMENTS
19.22 SENSYNE HEALTH PLC
19.22.1 COMPANY OVERVIEW
19.22.2 REVENUE ANALYSIS
19.22.3 GEOGRAPHIC PRESENCE
19.22.4 PRODUCT PORTFOLIO
19.22.5 RECENT DEVELOPEMENTS
19.23 BIOFOURMIS
19.23.1 COMPANY OVERVIEW
19.23.2 REVENUE ANALYSIS
19.23.3 GEOGRAPHIC PRESENCE
19.23.4 PRODUCT PORTFOLIO
19.23.5 RECENT DEVELOPEMENTS
19.24 SMARTPATIENT GMBH
19.24.1 COMPANY OVERVIEW
19.24.2 REVENUE ANALYSIS
19.24.3 GEOGRAPHIC PRESENCE
19.24.4 PRODUCT PORTFOLIO
19.24.5 RECENT DEVELOPMENTS
19.25 BOEHRINGER INGELHEIM
19.25.1 COMPANY OVERVIEW
19.25.2 REVENUE ANALYSIS
19.25.3 GEOGRAPHIC PRESENCE
19.25.4 PRODUCT PORTFOLIO
19.25.5 RECENT DEVELOPMENTS
19.26 BIG HEALTH
19.26.1 COMPANY OVERVIEW
19.26.2 REVENUE ANALYSIS
19.26.3 GEOGRAPHIC PRESENCE
19.26.4 PRODUCT PORTFOLIO
19.26.5 RECENT DEVELOPMENTS
19.27 COGNOA
19.27.1 COMPANY OVERVIEW
19.27.2 REVENUE ANALYSIS
19.27.3 GEOGRAPHIC PRESENCE
19.27.4 PRODUCT PORTFOLIO
19.27.5 RECENT DEVELOPMENTS
19.28 GLOOKO
19.28.1 COMPANY OVERVIEW
19.28.2 REVENUE ANALYSIS
19.28.3 GEOGRAPHIC PRESENCE
19.28.4 PRODUCT PORTFOLIO
19.28.5 RECENT DEVELOPMENTS
19.29 WELLDOC
19.29.1 COMPANY OVERVIEW
19.29.2 REVENUE ANALYSIS
19.29.3 GEOGRAPHIC PRESENCE
19.29.4 PRODUCT PORTFOLIO
19.29.5 RECENT DEVELOPMENTS
19.3 MEDRHYTHMS
19.30.1 COMPANY OVERVIEW
19.30.2 REVENUE ANALYSIS
19.30.3 GEOGRAPHIC PRESENCE
19.30.4 PRODUCT PORTFOLIO
19.30.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
20 RELATED REPORTS
21 CONCLUSION
22 QUESTIONNAIRE
23 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
